These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 31149566)

  • 1. Facial Papulopustular Eruption during the COVID-19 Pandemic in Patients Treated with EGFR Inhibitors.
    De Luca E; Sollena P; Di Nardo L; D'Argento E; Vita E; Tortora G; Peris K
    Dermatol Res Pract; 2024; 2024():8859032. PubMed ID: 38249546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy.
    Song CH; Jeong M; In H; Kim JH; Lin CW; Han KH
    Antibodies (Basel); 2023 Nov; 12(4):. PubMed ID: 37987250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines.
    Nowaczyk J; Fret K; Kaminska-Winciorek G; Rudnicka L; Czuwara J
    Anticancer Drugs; 2023 Sep; 34(8):942-948. PubMed ID: 36708507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Adverse Effects of Gefitinib: A Case Report.
    Jeria S; Thool AR; Daigavane S; Ganjre S
    Cureus; 2022 Sep; 14(9):e29600. PubMed ID: 36320985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panitumumab-Induced Paronychia: A Case Report and a Brief Review of the Literature.
    Yorulmaz A; Yalcin B
    Skin Appendage Disord; 2021 Feb; 7(2):123-126. PubMed ID: 33796558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scanning Electron Microscopy of Subclinical Gefitinib-Induced Hair Changes.
    de Almeida HL; Sartori DS; de Almeida AL; Ruas CP; Zerwes G
    Int J Trichology; 2020; 12(3):129-131. PubMed ID: 33223740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scanning Electron Microscopy of Erlotinib-induced Hair Changes: Pili Torti et Canaliculi.
    de Almeida HL; Sartori DS; Deves RP; Cruz OM
    Int J Trichology; 2019; 11(6):238-240. PubMed ID: 32030058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous side effects of EGFR inhibitors--appearance and management].
    Wollenberg A; Kroth J; Hauschild A; Dirschka T
    Dtsch Med Wochenschr; 2010 Jan; 135(4):149-54. PubMed ID: 20101558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: a dermatology-oncology perspective.
    Lacouture ME; Melosky BL
    Skin Therapy Lett; 2007; 12(6):1-5. PubMed ID: 17762902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Profile of Cutaneous Adverse Effects of Epidermal Growth Factor Receptor Inhibitors: A Prospective Observational Study of 76 Cases.
    Saraswat N; Sood A; Kumar D; Verma R; Sushil K
    Indian Dermatol Online J; 2019; 10(3):251-255. PubMed ID: 31149566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
    Štulhofer Buzina D; Martinac I; Ledić Drvar D; Čeović R; Bilić I; Marinović B
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):70-2. PubMed ID: 27149134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatological Side Effects of Epidermal Growth Factor Receptor Inhibitors: 'PRIDE' Complex.
    Madke B; Gole P; Kumar P; Khopkar U
    Indian J Dermatol; 2014 May; 59(3):271-4. PubMed ID: 24891659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted tumour therapy induced papulopustular rash and other dermatologic side effects: a retrospective study.
    Yalici-Armagan B; Ayanoglu BT; Demirdag HG
    Cutan Ocul Toxicol; 2019 Sep; 38(3):261-266. PubMed ID: 31010330
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermatological side effects of targeted antineoplastic therapies: a prospective study.
    Agirgol S; Çaytemel C; Pilanci KN
    Cutan Ocul Toxicol; 2020 Dec; 39(4):380-384. PubMed ID: 33028137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane.
    Macdonald JB; Macdonald B; Golitz LE; LoRusso P; Sekulic A
    J Am Acad Dermatol; 2015 Feb; 72(2):203-18; quiz 219-20. PubMed ID: 25592338
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.